Skip to main content

Table 3 Comparison of baseline clinical characteristics, DMSE and sub-factors of DMSE between intervention and control arms (N = 112)

From: Diabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in Pakistan: a randomized controlled trial

 

Total

DCM

RC

 

Clinical characteristics

N = 112(%)

n = 54(%)

n = 58(%)

Pvalue

Family history of diabetes

 Yes

85 (75.9)

41 (75.9)

44 (75.9)

0.994

 No

27 (24.1)

13 (24.1)

14 (24.1)

 Duration of diagnosis of diabetes (Mean ± SD yrs)

9.5 ± 5.8

10.2 ± 6.3

8.8 ± 5.3

0.209

 HbA1c at baseline (Mean ± SD)

9.3 ± 1.7

9.0 ± 1.5

10.0 ± 1.8

0.042

Comorbidities

 Hypertension

48 (92.3)

25 (92.6)

23 (92.0)

0.936

 Other (CHD, COPD)

4 (7.7)

2 (7.4)

2 (8.0)

 No information

  

Treatment

 Insulin

24 (21.4)

15 (27.8)

9 (15.5)

0.032

 Oral

62 (55.4)

23 (42.6)

39 (67.2)

 both

26 (23.2)

16 (29.6)

10 (17.9)

 Ovrall DMSE at baseline (Mean ± SD)

81.7 ± 17.2

81.6 ± 16.9

81.8 ± 17.4

0.938

 Factor 1:DMSE exercise & weight control (Mean ± SD)

36.5 ± 10.3

35.3 ± 9.8

37.6 ± 10.8

0.241

 Factor 2: Health seeking and diabetes treatment (Mean ± SD)

29.5 ± 7.1

30.6 ± 7.3

28.4 ± 6.8

0.112

 Factor 3:Blood sugar monitoring (Mean ± SD)

11.2 ± 2.7

11.1 ± 2.7

11.2 ± 2.7

0.72

 Factor 4:Diet control (Mean ± SD)

4.5 ± 1.9

4.6 ± 2.0

4.5 ± 1.7

0.798

  1. DCM Diabetes Conversation Map (Intervention arm), RC Routine care (Control arm)
  2. P values are two sided calculated based on Pearson chi-square or fisher exact test for the categorical variables and independent samples t test for the continuous variables